172937-63-2

Upstream product

• 172937-62-1 5-t-butyldiphenylsilyloxy-2-ethoxycarbonyl-1-oxo-1,2,3,4-tetrahydronaphthalene 

Downstream Products

• 172937-64-3 2-ethoxycarbonyl-5-t-butyldiphenylsilyloxy-3,4-dihydronaphthalene 
• 172937-81-4 2-(N,N-Diphenylcarbamoyloxymethyl)-5-t-butyldiphenylsilyloxy-3,4-dihydronaphthalene 
• 172936-75-3 2-(N,N-diphenylcarbamoyloxymethyl)-5-ethoxycarbonylmethyloxy-3,4-dihydronaphthalene 
• 782427-08-1 {6-[(diphenylcarbamoyloxy)-methyl]-7,8-dihydro-naphthalen-1-yloxy}-acetic acid 
• 172938-01-1 5-t-butyldiphenylsilyloxy-2-hydroxymethyl-3,4-dihydronaphthalene 

Relevant academic research and scientific papers

Discovery of diphenylcarbamate derivatives as highly potent and selective IP receptor agonists: Orally active prostacyclin mimetics. Part 3

The new classes of diphenylcarbamate derivatives with a tetrahydronaphthalene skeleton as highly potent and selective IP agonists have been discovered. The optimized diphenylcarbamate type compound FK-788: (R)-4 exhibited potent antiaggregative potency wi

Naphthalene derivatives as prostaglandin I2 agonsists

A compound of the formula STR1 wherein R1 is carboxy or protected carboxy, R2 is hydrogen, hydroxy or protected hydroxy, R3 is hydrogen, hydroxy, protected hydroxy, etc., R4 is hydrogen or halogen, A1